Glioblastomas, a deadly form of brain cancer, may be yet another cancer that responds to immunotherapy, a new Yale-led study suggests.

An analysis of brain tissue from glioblastoma patients shows immune system response to tumors was strengthened when exposed to an immunotherapy drug currently used to treat melanoma.